Thursday, 7 November 2013

MALARIA: Africa Fighting Malaria Updates and Events November 2013

Africa Fighting Malaria (AFM) seeks to raise awareness of the huge burden of malaria in sub-Saharan Africa and promote sensible policies for long-term solutions.
The quantification of parasite movements can provide valuable information for control strategy planning across all transmission intensities. Mobile parasite carrying individuals can instigate transmission in receptive areas, spread drug resistant strains and reduce the effectiveness of control strategies. The identification of mobile demographic groups, their routes of travel and how these movements connect differing transmission zones, potentially enables limited resources for interventions to be efficiently targeted over space, time and populations. 
Other News
Events and Information
The global malaria medicine chest could be boosted with a new drug researched and developed in Africa. MMV390048, a drug compound developed in Africa to combat malaria, is expected to go on phase I clinical trials within the first six months of next year, delegates attending the 6th Multilateral Initiative on Malaria Pan-African malaria conference in Durban, South Africa, were told early this month (8 October). The phase I trial in about 20 to 80 healthy volunteers will take place at the University of Cape Town's (UCT's) Groote Schuur Hospital.  

The World Health Organization issued a warning on Thursday that emerging drug-resistant malaria in the Greater Mekong Subregion could undo progress toward malaria control without urgent funding and action. Resistance to artemisinin, the front-line anti-malarial drug, was first confirmed on the Thailand-Cambodia border in 2008. The drug was also detected in Vietnam and Myanmar.
Also on

Please email Africa@fightingmalaria.orgfor more information.

No comments:

Post a Comment